RDS Library & Archives

Bad blood : (Record no. 105501)

MARC details
000 -LEADER
fixed length control field 01999pam a2200301 i 4500
001 - CONTROL NUMBER
control field 021201506
003 - CONTROL NUMBER IDENTIFIER
control field UkOxU
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20200127163834.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200127s2018 enk 001|0|eng|d
015 ## - NATIONAL BIBLIOGRAPHY NUMBER
National bibliography number GBB866731
Source bnb
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 018829532
Source Uk
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781509868063 : (hbk.)
Terms of availability £20.00
035 ## - SYSTEM CONTROL NUMBER
System control number (Uk)018829532
040 ## - CATALOGING SOURCE
Original cataloging agency StDuBDS
Language of cataloging eng
Description conventions rda
Transcribing agency StDuBDS
Modifying agency UkOxU
-- IeDuRDS
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 338.7681
Edition number 23
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Carreyrou, John
9 (RLIN) 135331
245 10 - TITLE STATEMENT
Title Bad blood :
Remainder of title secrets and lies in a Silicon Valley startup /
Statement of responsibility, etc. John Carreyrou.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture London :
Name of producer, publisher, distributor, manufacturer Picador,
Date of production, publication, distribution, manufacture, or copyright notice 2018.
300 ## - PHYSICAL DESCRIPTION
Extent x, 339 p. ;
Dimensions 24 cm
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
520 ## - SUMMARY, ETC.
Summary, etc. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.<br/><br/>Rigorously reported and fearlessly written, Bad Blood is a gripping story of the biggest corporate fraud since Enron—a tale of ambition and hubris set amid the bold promises of Silicon Valley.<br/>
600 10 - SUBJECT ADDED ENTRY--PERSONAL NAME
Personal name Holmes, Elizabeth,
9 (RLIN) 135332
Dates associated with a name 1984-
610 20 - SUBJECT ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element Theranos (Firm)
9 (RLIN) 135333
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hematologic equipment industry
Geographic subdivision United States.
9 (RLIN) 135335
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fraud
Geographic subdivision United States.
9 (RLIN) 97429
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Information technology
9 (RLIN) 51040
General subdivision Economic aspects.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Loanable Book
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Date last checked out Price effective from Koha item type
    Dewey Decimal Classification     General Collection Library Library 27/01/2020 1 338.7681 CAR 000438427 02/03/2020 13/02/2020 27/01/2020 Loanable Book

Powered by Koha